Investigation on Dabigatran Etexilate and Worsening of Renal Function in Patients With Atrial Fibrillation: The IDEA Study

Clinical Drug Investigation - United Kingdom
doi 10.1007/s40261-018-0742-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Resolution of Left Atrial Thrombus by Dabigatran Etexilate Administered During Acute-Phase Cardioembolic Stroke in Five Patients With Non-Valvular Atrial Fibrillation

Nosotchu
2015English

How to Use Dabigatran in Patients With Atrial Fibrillation

Rational Pharmacotherapy in Cardiology
Cardiovascular MedicinePharmacologyCardiology
2012English

Major Bleeding With Dabigatran and Rivaroxaban in Patients With Atrial Fibrillation

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2014English

Dabigatran Etexilate in Prevention of Stroke for Nonvalvular Atrial Fibrillation Patients in Turkish Health Care Setting; A Study on Cost Containment of Social Security Institution (SSI)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Treatments for Stroke Prevention in Atrial Fibrillation: A Network Meta-Analysis and Indirect Comparisons Versus Dabigatran Etexilate

Thrombosis and Haemostasis
Hematology
2010English

Dabigatran Versus Warfarin in Patients With Atrial Fibrillation: An Analysis of Patients Undergoing Cardioversion

Circulation
Cardiovascular MedicinePhysiologyCardiology
2011English

Pharmacoeconomic Analysis of Dabigatran in Patients With Atrial Fibrillation: Comparison With Rivaroxaban or Apixaban

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Risk Factors and Prevention of Dabigatran-Related Gastrointestinal Bleeding in Patients With Atrial Fibrillation

Journal of Arrhythmia
Cardiovascular MedicineCardiology
2017English

Possibility of Using Dabigatran in Patients With Atrial Fibrillation and Acute Coronary Syndrome and PCI

Medical Council
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy